A Study Comparing Oxymetazoline 1% Cream to RHOFADE

Inclusion Criteria: 1. Healthy male or non-pregnant female aged ≥18 years with a clinical diagnosis of facial rosacea; 2. Provided IRB approved written informed consent; 3. A CEA score of ≥3 prior to study drug application 4. A PSA score of ≥3 prior to study drug application Exclusion Criteria: 1. Female subjects who were pregnant, nursing, or had planned to become pregnant during study participation; 2. History of hypersensitivity to the study product; 3. Presence of ≥3 facial inflammatory lesions of rosacea; 4. Particular forms of rosacea (rosacea conglobata, rosacea fulminans, isolated rhinophyma, and isolated pustulosis of the chin); 5. Raynaud's syndrome, thromboangiitis obliterans, orthostatic hypotension, severe cardiovascular disease, cerebral or coronary insufficiency, renal or hepatic impairment, scleroderma, Sjögren's syndrome, or depression; 6. Excessive facial hair (e.g., beards, sideburns, moustaches, etc.) that could interfere with diagnosis or study assessments; 7. Presence of significant hypertension or circulatory disease